Titre du document / Document title
Pioneer study : PPARγ activation results in overall improvement of clinical and metabolic markers associated with insulin resistance independent of long-term glucose control
Auteur(s) / Author(s)
PFüTZNER A. ;
HOHBERG C. ;
LüBBEN G. ;
PAHLER S. ;
PFüTZNER A. H. ;
KANN P. ;
FORST T. ;
Résumé / Abstract
New scores and biochemical markers have recently been published for diagnosis of insulin resistance and β-cell dysfunction (such as intact proinsulin, adiponectin, IRISII-score). One goal of this 6-month prospective controlled study was to evaluate the impact of pioglitazone (45 mg) vs. glimepiride (1-6 mg, in the intend to optimize therapy) on these markers. Observation parameters were: IRIS-II score, HOMA-score, ATP III score, HbA
1c, fasting glucose, lipids, intact proinsulin, adiponectin, and adverse events. The study was completed by 173 patients (66 female, 107 male, age ′ STD: 63′8 years, disease duration: 7.2′7.2 years, HbA
1c: 7.53′0.85%, pioglitazone arm: 89 patients). The groups were not different for any of the observation parameters at baseline, and a similar reduction in HbA
1c was seen in both groups (p<0.001). In the pioglitazone group, reductions were observed for the IRIS-II and HOMA scores (p < 0.001 vs. glimepiride at endpoint) fasting glucose (p<0.001), insulin (p<0.001), LDL/HDL ratio (p<0.001), hsCRP (p<0.05), intact proinsulin (p<0.001), and an increase was seen in HDL (p<0.001), adiponectin (p<0.001) and BMI (p<0.001). In conclusion, treatment with pioglitazone resulted in an improvement of markers for insulin resistance and p-cell dysfunction, independent from blood glucose control. Adiponectin, intact proinsulin, and the IRIS-II score may be suitable parameters for monitoring of these additional beneficial therapeutic effects.
Revue / Journal Title
Hormone and metabolic research
ISSN 0018-5043
CODEN HMMRA2
Source / Source
2005, vol. 37, n
o8, pp. 510-515 [6 page(s) (article)]
Langue / Language
Anglais
Editeur / Publisher
Thieme, Stuttgart, ALLEMAGNE
(1969)
(Revue)
Mots-clés d'auteur / Author Keywords
Intact proinsulin ;
Adiponectin ;
IRIS-II score ;
HOMA score ;
Localisation / Location
INIST-CNRS, Cote INIST : 14356, 35400013187753.0090
Nº notice refdoc (ud4) : 17074482